Novo Can't Get 'Deceptive' Lilly GLP-1 Ads Blocked Amid Suit
A New Jersey federal judge on Monday refused to issue an injunction blocking Eli Lilly & Co. from running ads allegedly comparing its GLP-1 drug to Novo Nordisk Inc.'s using "outdated"...To view the full article, register now.
Already a subscriber? Click here to view full article